TrialAmerican journal of respiratory and critical care medicine2015
Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension.
Edda Spiekerkoetter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
76 papers cite itlatest 60 shown
this paperpooled ittrialcites it